The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patient-derived bladder cancer xenografts as a platform for drug development in bladder cancer.
 
Amy Wang Pan
No Relationships to Disclose
 
Hongyong Zhang
No Relationships to Disclose
 
Tzu-yin Lin
Employment - LP Therapeutics
Stock and Other Ownership Interests - LP Therapeutics
 
Yuanpei Li
Employment - Lamno Therapeutics
Stock and Other Ownership Interests - Lamno Therapeutics
Consulting or Advisory Role - LP Therapeutics
 
Tianhong Li
Speakers' Bureau - Pfizer
Research Funding - Astellas Pharma (Inst); Lilly (Inst); Novartis (Inst)
 
James Keck
No Relationships to Disclose
 
Clifford Tepper
No Relationships to Disclose
 
Susan D. Airhart
No Relationships to Disclose
 
Edison T. Liu
No Relationships to Disclose
 
Chong-xian Pan
Stock and Other Ownership Interests - Accelerated Medical Diagnostics; LP Therapeutics
Consulting or Advisory Role - Novartis
Research Funding - Abbott Diagnostics; Altor BioScience; Novartis
 
Ralph de Vere White
No Relationships to Disclose
 
Kit S. Lam
Stock and Other Ownership Interests - Lamno Therapeutics; LP Therapeutics